These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38866268)

  • 1. Tacrolimus-loaded chitosan-based nanoparticles as an efficient topical therapeutic for the effective treatment of atopic dermatitis symptoms.
    Lee JS; Oh E; Oh H; Kim S; Ok S; Sa J; Lee JH; Shin YC; Bae YS; Choi CY; Lee S; Kwon HK; Yang S; Choi WI
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):133005. PubMed ID: 38866268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose.
    Yu K; Wang Y; Wan T; Zhai Y; Cao S; Ruan W; Wu C; Xu Y
    Int J Nanomedicine; 2018; 13():129-142. PubMed ID: 29317821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC/Nga mice.
    Noguchi A; Tominaga M; Takahashi N; Matsuda H; Kamata Y; Umehara Y; Ko KC; Suga Y; Ogawa H; Takamori K
    J Dermatol Sci; 2017 Apr; 86(1):54-62. PubMed ID: 28069324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects.
    Wang Y; Cao S; Yu K; Yang F; Yu X; Zhai Y; Wu C; Xu Y
    Int J Nanomedicine; 2019; 14():5849-5863. PubMed ID: 31440050
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced topical delivery of tacrolimus by a carbomer hydrogel formulation with transcutol P.
    Lee SG; Kang JB; Kim SR; Kim CJ; Yeom DW; Yoon HY; Kwak SS; Choi YW
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1636-42. PubMed ID: 26925849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis.
    Pople PV; Singh KK
    Eur J Pharm Biopharm; 2013 May; 84(1):72-83. PubMed ID: 23246619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.
    Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN
    Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations.
    Jain S; Addan R; Kushwah V; Harde H; Mahajan RR
    Int J Pharm; 2019 May; 562():96-104. PubMed ID: 30902706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits.
    Ohtsuki M; Morimoto H; Nakagawa H
    J Dermatol; 2018 Aug; 45(8):936-942. PubMed ID: 29927498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus-loaded chitosan nanoparticles for enhanced skin deposition and management of plaque psoriasis.
    Fereig SA; El-Zaafarany GM; Arafa MG; Abdel-Mottaleb MMA
    Carbohydr Polym; 2021 Sep; 268():118238. PubMed ID: 34127220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis-Part II: in vivo assessment of dermatopharmacokinetics, biodistribution and efficacy.
    Pople PV; Singh KK
    Int J Pharm; 2012 Sep; 434(1-2):70-9. PubMed ID: 22609427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisone-loaded chitosan nanoparticles.
    Hussain Z; Katas H; Mohd Amin MC; Kumolosasi E; Sahudin S
    Int J Nanomedicine; 2014; 9():5143-56. PubMed ID: 25395851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation.
    Li G; Fan Y; Fan C; Li X; Wang X; Li M; Liu Y
    Eur J Pharm Biopharm; 2012 Sep; 82(1):49-57. PubMed ID: 22705640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.
    Simpson D; Noble S
    Drugs; 2005; 65(6):827-58. PubMed ID: 15819596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual roles of TPGS based microemulsion for tacrolimus: Enhancing the percutaneous delivery and anti-psoriatic efficacy.
    Wan T; Pan J; Long Y; Yu K; Wang Y; Pan W; Ruan W; Qin M; Wu C; Xu Y
    Int J Pharm; 2017 Aug; 528(1-2):511-523. PubMed ID: 28629978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on the effects of topical therapy with 0.1% tacrolimus ointment (Protopic) on intradermal skin test reactivity in atopic dogs.
    Marsella R; Nicklin CF; Saglio S; Lopez J
    Vet Dermatol; 2004 Aug; 15(4):218-24. PubMed ID: 15305928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved tacrolimus skin permeation by co-encapsulation with clobetasol in lipid nanoparticles: Study of drug effects in lipid matrix by electron paramagnetic resonance.
    Andrade LM; Silva LAD; Krawczyk-Santos AP; Amorim ICSM; Rocha PBRD; Lima EM; Anjos JLV; Alonso A; Marreto RN; Taveira SF
    Eur J Pharm Biopharm; 2017 Oct; 119():142-149. PubMed ID: 28627400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis.
    Gabriel D; Mugnier T; Courthion H; Kranidioti K; Karagianni N; Denis MC; Lapteva M; Kalia Y; Möller M; Gurny R
    J Control Release; 2016 Nov; 242():16-24. PubMed ID: 27639683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
    Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.